These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23711790)
41. The interplay between Src and integrins in normal and tumor biology. Playford MP; Schaller MD Oncogene; 2004 Oct; 23(48):7928-46. PubMed ID: 15489911 [TBL] [Abstract][Full Text] [Related]
42. Integrins in cancer: Emerging mechanisms and therapeutic opportunities. Liu F; Wu Q; Dong Z; Liu K Pharmacol Ther; 2023 Jul; 247():108458. PubMed ID: 37245545 [TBL] [Abstract][Full Text] [Related]
43. [Adhesion molecules and cancer metastasis]. Ota I; Matsuura S Rinsho Byori; 1997 Jun; 45(6):528-33. PubMed ID: 9306710 [TBL] [Abstract][Full Text] [Related]
44. Integrins in the Spotlight of Cancer. Bianconi D; Unseld M; Prager GW Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27929432 [TBL] [Abstract][Full Text] [Related]
45. Molecular Targeting of Integrins and Integrin-Associated Signaling Networks in Radiation Oncology. Vehlow A; Storch K; Matzke D; Cordes N Recent Results Cancer Res; 2016; 198():89-106. PubMed ID: 27318682 [TBL] [Abstract][Full Text] [Related]
46. Integrin-independent support of cancer drug resistance by tetraspanin CD151. Hwang S; Takimoto T; Hemler ME Cell Mol Life Sci; 2019 Apr; 76(8):1595-1604. PubMed ID: 30778617 [TBL] [Abstract][Full Text] [Related]
47. Targeting Integrins for Cancer Therapy - Disappointments and Opportunities. Bergonzini C; Kroese K; Zweemer AJM; Danen EHJ Front Cell Dev Biol; 2022; 10():863850. PubMed ID: 35356286 [TBL] [Abstract][Full Text] [Related]
49. Integrins regulate stemness in solid tumor: an emerging therapeutic target. Xiong J; Yan L; Zou C; Wang K; Chen M; Xu B; Zhou Z; Zhang D J Hematol Oncol; 2021 Oct; 14(1):177. PubMed ID: 34715893 [TBL] [Abstract][Full Text] [Related]
50. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Seguin L; Desgrosellier JS; Weis SM; Cheresh DA Trends Cell Biol; 2015 Apr; 25(4):234-40. PubMed ID: 25572304 [TBL] [Abstract][Full Text] [Related]
51. Integrins: a method of early intervention in the treatment of colorectal liver metastases. Robertson JH; Iga AM; Sales KM; Winslet MC; Seifalian AM Curr Pharm Des; 2008; 14(3):296-305. PubMed ID: 18220840 [TBL] [Abstract][Full Text] [Related]
52. Roles of integrin in tumor development and the target inhibitors. Li ZH; Zhou Y; Ding YX; Guo QL; Zhao L Chin J Nat Med; 2019 Apr; 17(4):241-251. PubMed ID: 31076128 [TBL] [Abstract][Full Text] [Related]
53. Alpha-v integrins as therapeutic targets in oncology. Nemeth JA; Nakada MT; Trikha M; Lang Z; Gordon MS; Jayson GC; Corringham R; Prabhakar U; Davis HM; Beckman RA Cancer Invest; 2007 Oct; 25(7):632-46. PubMed ID: 18027153 [TBL] [Abstract][Full Text] [Related]
56. Integrins in cancer treatment. Eble JA; Haier J Curr Cancer Drug Targets; 2006 Mar; 6(2):89-105. PubMed ID: 16529540 [TBL] [Abstract][Full Text] [Related]
57. Integrin as a Molecular Target for Anti-cancer Approaches in Lung Cancer. Aksorn N; Chanvorachote P Anticancer Res; 2019 Feb; 39(2):541-548. PubMed ID: 30711928 [TBL] [Abstract][Full Text] [Related]
58. Integrins as A New Target for Cancer Treatment. Łasiñska I; Mackiewicz J Anticancer Agents Med Chem; 2019; 19(5):580-586. PubMed ID: 30451118 [TBL] [Abstract][Full Text] [Related]
59. Molecular Modeling Insights into the Structure and Behavior of Integrins: A Review. Tvaroška I; Kozmon S; Kóňa J Cells; 2023 Jan; 12(2):. PubMed ID: 36672259 [TBL] [Abstract][Full Text] [Related]
60. Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer. Ata R; Antonescu CN Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]